<DOC>
	<DOC>NCT01816607</DOC>
	<brief_summary>The purpose of this study is to establish a reliable method for detection of rectal cancer patients with aggressive tumor at risk of metastatic disease and death by functional MRI.</brief_summary>
	<brief_title>Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Rectal Neoplasms</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Digestive System Neoplasms</mesh_term>
	<mesh_term>Rectal Diseases</mesh_term>
	<mesh_term>Aggression</mesh_term>
	<criteria>The patient is willing and able to give full written consent according to the protocol approved by the Regional Ethics Committee. The patient has confirmed rectal cancer diagnosis and is scheduled to radical surgery alone or preoperative CRT followed by surgery. The patient is ≥ 18 years. The patient has no prior rectal cancer treatment. The patient has adequate renal function: creatinine clearance ≥ 60 ml/minute. The patient has signed the written informed consent according to the protocol approved by the Regional Ethics Committee. The patient has contraindication to MRI or MRI contrast agent according to clinical practice. The patient wants to withdraw for any reason during the study.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Magnetic Resonance Imaging</keyword>
	<keyword>Magnetic Resonance Imaging, Functional</keyword>
</DOC>